In-Vitro Toxicology Testing Market Size, Growth, Trends, Demand, Revenue and Future Outlook
In-Vitro Toxicology Testing Market Growth, Trends, Analysis, Size- By Method, By End User, By Technology, By Application- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Aug-2024 | Report ID: HLCA2470 | Pages: 1 - 243 | Formats*: |
| Category : Healthcare | |||
In- Vitro Toxicology Testing Market Introduction and Overview
According to SPER Market Research, the Global In-Vitro Toxicology Testing Market is estimated to reach USD 34.76 billion by 2033 with a CAGR of 11.05%.
The report includes an in-depth analysis of the Global In-Vitro Toxicology Testing Market, including market size and trends, product mix, applications, and supplier analysis. Experiments employing separated body tissues, organs, or cells are referred to as in vitro toxicity testing. By monitoring the impact of chemicals on these biological systems, these experiments seek to understand their toxicity. In the early stages of product development, the main goals are to find safe exposure thresholds, identify potentially harmful effects, and screen for side effects. Cell-Based Assays, these testing methods evaluate the cellular reactions of harmful chemicals by use of cultivated cell lines. Second are Tissue-Based Assays, which assess a substance's effects on certain tissues or organs using tissue cultures or explants. Organ-on-Chip Models, these sophisticated models imitate human organ functioning on microchips, enabling more intricate and precise toxicity calculations.
- September 2019; In an effort to expand its in-vitro toxicology testing business throughout Asia Pacific, Covance, based in Shanghai, opened a new R&D facility in China.
- August 2019; Abbott established a partnership with Intoximeters to market the SoToxa Mobile Test System, a portable oral fluid solution for drug and alcohol testing, in the US. Amphetamine, benzodiazepines, cocaine, methamphetamine, opiates, and cannabis (THC) can all be detected by the device.
- August 2019; Covance expanded their functional vendor (FSPx) offering to include clinical analytics services, clinical operations capabilities, and an analytical laboratory component.
Market Opportunities and Challenges
Opportunities- Continuous advancements in toxicological research and technological advancements are credited with the market's growth. Further projected to support the market is the growing emphasis on the creation of customized medications. People are becoming more and more aware of the drawbacks and difficulties of using conventional toxicological screening techniques. Because of this, in-vitro testing is now more widely recognized as a useful method for determining the safety and effectiveness of different chemicals. In vitro and alternative testing procedures have seen a substantial increase in validation and adoption by regulatory bodies in recent times. Increased usage of in vitro screening and monitoring models has resulted from ongoing technological developments aimed at replacing animal testing in toxicology.
Challenges- For in vitro testing to be considered a valid alternative to or supplement to animal testing, it must be approved by numerous regulatory bodies. This can be a drawn-out and difficult procedure. Standardized protocols are necessary to guarantee uniformity in testing methods and outcomes throughout various labs and research projects. The intricacy of human physiology, which includes metabolism, immunological responses, and interactions among multiple organs, is frequently not accurately reflected in in vitro models. This reduces their ability to accurately forecast how chemicals would affect entire species. The significance of the results may be impacted if commonly utilized cell lines do not adequately represent human tissue types or situations.
Market Competitive Landscape
The global In-vitro Toxicology Testing industry is home to several major players, including GE Healthcare, Quest Diagnostics Incorporated, Evotec, Creative Bioarray, Gentronix, BioIVT, SGS SA, Abbott, Merck KGaA, Charles River, Bio-Rad Laboratories, Inc, Quest Diagnostics Incorporated, Catalent, Inc, AGILENT TECHNOLOGIES.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Method, By End Use, By Technology, By Application |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Abbott, Agilent Technologies, BioIVT, Bio-Rad Laboratories, Inc, Catalent, Inc, Charles River, Creative Bioarray, Evotec, Eurofins Scientific, GE Healthcare, Gentronix, Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, SGS SA, Thermo Fisher Scientific Inc. |
COVID-19 Impact on Global In- Vitro Toxicology Testing Market
The market for in vitro toxicity tests has been significantly impacted by the COVID-19 epidemic. Due to the pandemic's disruption, there were shortages of necessary supplies and reagents for in vitro toxicity testing. This affected the laboratories' capacity to perform tests and satisfy requests. Timelines for testing and research were impacted by delays in the supply of essential supplies and equipment caused by restrictions and lockdowns. Research funds and priorities were redirected toward COVID-19-related research, vaccine development, and antiviral medications because to the pressing need to fight the pandemic. As a result, non-COVID-related toxicology research received less funding and attention than other fields.
Key Target Audience:
- Contract Research Organizations (CROs)
- Regulatory Agencies
- Academic and Research Institutions
- Chemical and Cosmetic Companies
- Healthcare and Medical Device Companies
- Environmental and Consumer Safety Organizations
- Insurance and Risk Management Firms
- Regulatory Consultants and Advisors
- Investors and Venture Capitalists
Our in-depth analysis of the Global In- Vitro Toxicology Testing Market includes the following segments:
| By Method: | |
| By End Use: | |
| By Technology: | |
| By Application: |
Key Topics Covered in the Report:
- Global In-Vitro Toxicology Testing Market Size (FY’2024-FY’2033)
- Overview of Global In-Vitro Toxicology Testing Market
- Segmentation of Global In-Vitro Toxicology Testing Market by Method (Cellular Assay {Live Cells, Fixed Cells}, Biochemical Assay, in-Silico, Ex- Vivo)
- Segmentation of Global In-Vitro Toxicology Testing Market by End-Use (Pharmaceutical Industry, Cosmetics and Household Products, Academic Institutes and Research Laboratories, Diagnostics, Chemical Industry, Food industry)
- Segmentation of Global In-Vitro Toxicology Testing Market by Technology (Cell Culture Technology, High Throughput Technology, Molecular Imaging, OMICS Technology)
- Segmentation of Global In-Vitro Toxicology Testing Market by Application (Systemic Toxicology, Dermal Toxicity, Endocrine Disruptions, Ocular Toxicity, Other Applications)
- Statistical Snap of Global In-Vitro Toxicology Testing Market
- Expansion Analysis of Global In-Vitro Toxicology Testing Market
- Problems and Obstacles in Global In-Vitro Toxicology Testing Market
- Competitive Landscape in the Global In-Vitro Toxicology Testing Market
- Impact of COVID-19 and Demonetization on Global In-Vitro Toxicology Testing Market
- Details on Current Investment in Global In-Vitro Toxicology Testing Market
- Competitive Analysis of Global In-Vitro Toxicology Testing Market
- Prominent Players in the Global In-Vitro Toxicology Testing Market
- SWOT Analysis of Global In-Vitro Toxicology Testing Market
- Global In-Vitro Toxicology Testing Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Global In-Vitro Toxicology Testing Market
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global In-Vitro Toxicology Testing Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global In-Vitro Toxicology Testing Market
7. Global In-Vitro Toxicology Testing Market, By Method (USD Million) 2020-2033
7.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Method, 2020-20267.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Method, 2027-20337.3. Cellular Assay7.3.1. Live Cells7.3.2. Fixed Cells7.4. Biochemical Assay7.5. In-Silico7.6. Ex-vivo
8. Global In-Vitro Toxicology Testing Market, By End Use (USD Million) 2020-2033
8.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By End Use, 2020-20268.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By End Use, 2027-20338.3. Pharmaceutical Industry8.4. Cosmetics & Household Products8.5. Academic Institutes and Research Laboratories8.6. Diagnostics8.7. Chemical Industry8.8. Food Industry
9. Global In-Vitro Toxicology Testing Market, By Technology (USD Million) 2020-2033
9.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Technology, 2020-20269.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Technology, 2027-20339.3. Cell Culture Technology9.4. High Throughput Technology9.5. Molecular Imaging9.6. OMICS Technology
10. Global In-Vitro Toxicology Testing Market, By Application (USD Million) 2020-2033
10.1. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Application, 2020-202610.2. Global In-Vitro Toxicology Testing Market Size, Share and Forecast, By Application 2027-203310.3. Systemic Toxicology10.4. Dermal Toxicity10.5. Endocrine Disruption10.6. Ocular Toxicity10.7. Other Applications
11. Global In-Vitro Toxicology Testing Market Forecast, 2020-2033 (USD Million)
11.1. Global In-Vitro Toxicology Testing Market Size and Market Share
12. Global In-Vitro Toxicology Testing Market, By Region, 2020-2033 (USD Million)
12.1. Global In-Vitro Toxicology Testing Market Size and Market Share By Region (2020-2026)12.2. Global In-Vitro Toxicology Testing Market Size and Market Share By Region (2027-2033)12.3. Asia-Pacific12.3.1. Australia12.3.2. China12.3.3. India12.3.4. Japan12.3.5. South Korea12.3.6. Rest of Asia-Pacific12.4. Europe12.4.1. France12.4.2. Germany12.4.3. Italy12.4.4. Spain12.4.5. United Kingdom12.4.6. Rest of Europe12.5. Middle East and Africa12.5.1. Kingdom of Saudi Arabia12.5.2. United Arab Emirates12.5.3. Qatar12.5.4. South Africa12.5.5. Egypt12.5.6. Morocco12.5.7. Nigeria12.5.8. Rest of Middle-East and Africa12.6. North America12.6.1. Canada12.6.2. Mexico12.6.3. United States12.7. Latin America12.7.1. Argentina12.7.2. Brazil12.7.3. Rest of Latin America
13. Company Profile
13.1. ABBOTT13.1.1. Company details13.1.2. Financial outlook13.1.3. Product summary13.1.4. Recent developments13.2. AGILENT TECHNOLOGIES13.2.1. Company details13.2.2. Financial outlook13.2.3. Product summary13.2.4. Recent developments13.3. BIO-RAD LABORATORIES, INC13.3.1. Company details13.3.2. Financial outlook13.3.3. Product summary13.3.4. Recent developments13.4. CATALENT, INC13.4.1. Company details13.4.2. Financial outlook13.4.3. Product summary13.4.4. Recent developments13.5. EUROFINS SCIENTIFIC13.5.1. Company details13.5.2. Financial outlook13.5.3. Product summary13.5.4. Recent developments13.6. GE HEALTHCARE13.6.1. Company details13.6.2. Financial outlook13.6.3. Product summary13.6.4. Recent developments13.7. MERCK KGAA13.7.1. Company details13.7.2. Financial outlook13.7.3. Product summary13.7.4. Recent developments13.8. QUEST DIAGNOSTICS INCORPORATED13.8.1. Company details13.8.2. Financial outlook13.8.3. Product summary13.8.4. Recent developments13.9. THERMO FISHER SCIENTIFIC INC13.9.1. Company details13.9.2. Financial outlook13.9.3. Product summary13.9.4. Recent developments13.10. Others
14. Conclusion
15. List of Abbreviations
16. Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
In-Vitro Toxicology Testing Market is projected to reach 34.76 billion by 2033, growing at a CAGR of 11.05% during the forecast period.
In-Vitro Toxicology Testing Market grew in Market size from 2024. The Market is expected to reach 34.76 billion by 2033, at a CAGR of 11.05% during the forecast period.
In-Vitro Toxicology Testing Market CAGR of 11.05% during the forecast period.
You can get the sample pages by clicking the link - Click Here
In-Vitro Toxicology Testing Market size is 34.76 billion from 2024 to 2033.
In-Vitro Toxicology Testing Market is covered By Method, By End Use, By Technology, By Application
The North America is anticipated to have the highest Market share in the In-Vitro Toxicology Testing Market.
The key players in the Market include Companies Covered Abbott, Agilent Technologies, BioIVT, Bio-Rad Laboratories, Inc, Catalent, Inc, Charles River, Creative Bioarray, Evotec, Eurofins Scientific, GE Healthcare, Gentronix, Laboratory Corporation of America Holdings, Merck KGaA, Quest Diagnostics Incorporated, SGS SA, Thermo Fisher Scientific Inc.
The high cost of advanced diabetes drugs and the financial burden of treating diabetes remain major obstacles to market growth, despite the fact that numerous drugs have been approved for the condition and that governments and industry players are launching numerous initiatives.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
